Klaus Kammerer

Learn More
The increasing adoption of process-aware information systems (PAISs) has resulted in large process model collections. To support users having different perspectives on these processes and related data, a PAIS should provide personalized views on process models. Existing PAISs, however, do not provide mechanisms for creating or even changing such process(More)
Neurokinin-1 receptor antagonists (NK1 RAs) are commonly coadministered with a 5-HT3 RA such as palonosetron to prevent nausea and vomiting induced by chemotherapy. Netupitant, a new highly selective NK1 RA, is both a substrate for and a moderate inhibitor of CYP3A4. Three studies were designed to evaluate the potential drug–drug interaction of netupitant(More)
The increasing adoption of process-aware information systems (PAISs) has resulted in large process repositories comprising large and complex process models. To enable context-specific perspectives on these process models and related data, a PAIS should provide techniques for the flexible creation and change of process model abstractions. However, existing(More)
The increasing adoption of process-aware information systems (PAISs) has resulted in large process model collections. To support users having different perspectives on these processes and related data, a PAIS should provide personalized views on process models. Especially, changing process models is a frequent use case in PAISs due to evolving business(More)
A discussion forum was hosted by the German not-for-profit Association for Applied Human Pharmacology (AGAH e.V.) to critically review key eligibility criteria and stopping rules for clinical trials with healthy subjects, enrolling stakeholders from the pharmaceutical industry, contract research organisations, academia, ethics committees and competent(More)
Collaborative process modeling involves business analysts and subject matter experts in order to properly capture and document process knowledge. In this context, appropriate tool support is required to motivate these user groups to actively participate in collaborative process modeling. This paper presents a collaborative process modeling tool that enables(More)
Faldaprevir (FDV) is a potent, orally administered inhibitor of hepatitis C virus protease. It inhibits multiple cytochrome P-450 enzymes and multiple membrane transporters. The objective of this study was to evaluate the effect of steady-state faldaprevir on the pharmacokinetics (PK) of a single dose of atorvastatin or rosuvastatin. In this single-center,(More)
Today’s enterprises face individual customer expectations, high product variability, and an abundance of regulations. Consequently, they must cope with numerous business process variants, whose design and execution depend on a multiplicity of influencing factors, like, e.g., customer requests, resource availability, compliance rules, or process data.(More)
The increasing adoption of process-aware information systems (PAISs) has resulted in large process model collections involving different process participants. We present the Clavii BPM platform, which enables end users to participate not only in process model execution, but model creation as well. Clavii offers a modern user interface with a strong focus on(More)
  • 1